News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
73,435 Results
Type
Article (1921)
Company Profile (2)
Press Release (71512)
Section
Business (25345)
Career Advice (9)
Deals (4554)
Drug Development (8162)
FDA (1804)
Job Trends (800)
News (37038)
Policy (3565)
Tag
2027 BioCapital Standard (1)
Academia (98)
Accelerated approval (5)
ADA (2)
Allergies (23)
Alliances (8172)
ALS (15)
Alzheimer's disease (184)
Antibody-drug conjugate (ADC) (117)
Approvals (1970)
Artificial intelligence (35)
ASCO (38)
Autoimmune disease (39)
Automation (2)
Bankruptcy (8)
Best Places to Work (585)
BIO (9)
Biosimilars (94)
Biotechnology (5)
Bladder cancer (32)
Brain cancer (8)
Breast cancer (64)
Cancer (655)
Cardiovascular disease (26)
Career advice (9)
CAR-T (16)
CDC (1)
Cell therapy (60)
Cervical cancer (5)
Clinical research (7700)
Collaboration (341)
Commercialization (1)
Compensation (27)
Complete response letters (7)
COVID-19 (199)
CRISPR (1)
C-suite (96)
Cystic fibrosis (8)
Data (854)
Depression (16)
Dermatology (11)
Diabetes (44)
Diagnostics (645)
Digital health (7)
Drug discovery (42)
Drug pricing (1)
Duchenne muscular dystrophy (43)
Earnings (8175)
Events (7603)
Executive appointments (75)
FDA (2319)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (158)
Gene editing (7)
Generative AI (1)
Gene therapy (41)
GLP-1 (81)
Government (241)
Grass and pollen (1)
Guidances (39)
Healthcare (1094)
Hematology (14)
HIV (7)
Huntington's disease (3)
IgA nephropathy (23)
Immunology and inflammation (8)
Immuno-oncology (11)
Indications (28)
Infectious disease (225)
Inflammatory bowel disease (25)
Inflation Reduction Act (1)
Influenza (14)
Intellectual property (41)
IPO (1640)
Job creations (241)
Job search strategy (9)
JPM (3)
Kidney cancer (2)
Layoffs (6)
Legal (953)
Liver cancer (19)
Longevity (3)
Lung cancer (118)
Lymphoma (56)
Machine learning (1)
Manufacturing (132)
Marketing (4)
MASH (19)
Medical device (1170)
Medtech (1188)
Mergers & acquisitions (3115)
Metabolic disorders (113)
mRNA (7)
Multiple sclerosis (25)
NASH (1)
Neurodegenerative disease (35)
Neuropsychiatric disorders (7)
Neuroscience (339)
NextGen: Class of 2026 (218)
Non-profit (64)
Obesity (38)
Opinion (1)
Ovarian cancer (35)
Pain (20)
Pancreatic cancer (31)
Parkinson's disease (49)
Partnered (4)
Patents (76)
Patient recruitment (80)
Peanut (1)
People (5186)
Pharmaceutical (2)
Pharmacy benefit managers (5)
Phase 1 (2081)
Phase 2 (3260)
Phase 3 (2904)
Pipeline (1232)
Policy (1)
Postmarket research (241)
Preclinical (712)
Press Release (2)
Prostate cancer (28)
Radiopharmaceuticals (25)
Rare diseases (85)
Real estate (606)
Regulatory (3060)
Reports (6)
Research institute (97)
Rett syndrome (1)
RNA editing (3)
RSV (3)
Schizophrenia (21)
Series A (35)
Series B (24)
Service/supplier (1)
Sickle cell disease (8)
Spinal muscular atrophy (5)
Sponsored (1)
Startups (425)
Stomach cancer (3)
Supply chain (13)
Vaccines (46)
Venture capital (7)
Weight loss (17)
Women's health (7)
Date
Today (2)
Last 7 days (40)
Last 30 days (179)
Last 365 days (2815)
2026 (1637)
2025 (2695)
2024 (3260)
2023 (3823)
2022 (7013)
2021 (6377)
2020 (5870)
2019 (3857)
2018 (3010)
2017 (3559)
2016 (3171)
2015 (4031)
2014 (3023)
2013 (2600)
2012 (2775)
2011 (2903)
2010 (2663)
Location
Africa (88)
Alabama (4)
Arizona (13)
Arkansas (1)
Asia (22321)
Australia (2485)
California (807)
Canada (469)
China (520)
Colorado (5)
Connecticut (23)
Delaware (6)
Europe (13439)
Florida (88)
Georgia (17)
Illinois (44)
India (53)
Indiana (27)
Japan (341)
Kansas (5)
Louisiana (2)
Maine (4)
Maryland (124)
Massachusetts (638)
Michigan (9)
Minnesota (38)
Missouri (3)
Nebraska (3)
Nevada (10)
New Hampshire (1)
New Jersey (490)
New York (286)
North Carolina (125)
Northern California (343)
Ohio (6)
Oregon (1)
Pennsylvania (151)
Puerto Rico (1)
Rhode Island (1)
South America (109)
South Carolina (1)
Southern California (395)
Tennessee (4)
Texas (61)
United States (3088)
Utah (30)
Vermont (1)
Virginia (60)
Washington D.C. (3)
Washington State (61)
Wisconsin (8)
73,435 Results for "keymed ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Keymed Biosciences Announces 2025 Annual Results and Business Updates
March 27, 2026
·
10 min read
Press Releases
Keymed Biosciences (02162.HK) Reports Strong Interim 2025 Results with Accelerated Commercialization and Robust R&D Momentum
August 27, 2025
·
1 min read
Press Releases
Keymed Biosciences Announces Annual Results of 2024
March 27, 2025
·
12 min read
Business
Keymed Biosciences Announces 2023 Annual Results and Business Updates
Keymed Biosciences Inc. (HKEX: 02162) today announced its 2023 annual results, along with recent pipeline highlights and corporate updates.
March 26, 2024
·
9 min read
Press Releases
Propanc Biopharma Signs MOU with Avance Clinical Pty Ltd
July 7, 2026
·
5 min read
Press Releases
Keymed Biosciences Announces the Latest Clinical Trial Results of CM336 Published in the New England Journal of Medicine
June 13, 2025
·
2 min read
Press Releases
Faron Pharmaceuticals Ltd: Registration of Treasury Shares
June 11, 2026
·
2 min read
Keymed Biosciences Announces Safety and Efficacy Results of CM313 for Primary Immune Thrombocytopenia Published in NEJM
Keymed Biosciences Inc. announced that Lei Zhang/Renchi Yang’s team from the Institute of Hematology, Chinese Academy of Medical Sciences has recently published a research paper entitled “A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia” in the New England Journal of Medicine.
June 20, 2024
·
2 min read
Press Releases
Faron Pharmaceuticals Ltd: Grant of Options - July 1, 2026
July 1, 2026
·
5 min read
Press Releases
Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis
February 9, 2025
·
2 min read
1 of 7,344
Next
